Are these FTSE 250 flyers getting too expensive?

These two companies are flying but Harvey Jones sees no reason why investors should get their wings burned.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

These two FTSE 250 companies have been flying over the past five years. Is there a danger they could suddenly come crashing back to earth?

Spirax spirals

Spirax-Sarco Engineering (LSE: SPX) is a multinational engineering group made up of two businesses, Spirax Sarco for steam specialities and Watson-Marlow for niche peristaltic pumps and associated fluid path technologies. Its job is to help customers save energy and water, boost efficiency, improve product quality and make improvements in plant health, safety and regulatory compliance.

The company’s share price has soared a dizzying 70% in the past 12 months and is up 180% over five years. Earlier this month it comforted investors by reporting that anticipated, organic sales growth in the first four months of the year beat last year’s. It expects sales and profits to rise 5% and 8% respectively year-on-year, at broadly constant currency rates.

Cash is king

Spirax-Sarco Engineering is growing through acquisition, buying steam specialities business Gestra for £160m earlier this month, and long-term target US electrical products provider Chromalox for £319m, in a cash and debt-free transaction last week. The purchase fits nicely alongside its existing operations and the company’s share price bounced more than 8% on Friday.

There is just one sticking point: the company currently trades at a pricey 33.25 times earnings. This is partly justified by its growth prospects, with earnings per share (EPS) forecast to rise a hefty 19% this calendar year, and another 8% in 2018. Even that will only reduce the valuation to 26.5 times earnings. Revenues and profits look set to rise strongly, although this cash generative business only yields 1.33%. It nonetheless looks a tempting buy, with a net cash balance of £60m prior to the Gestra acquisition, although possibly one to save for a market dip.

Get real

Assura Group (LSE: AGR) is the UK’s leading healthcare real estate investment trust, specialising in designing, building and managing a portfolio of nearly 400 GP surgery buildings and primary care centres. Recent share price growth has been so-so and the stock is up just 7% over the past year. But over five years it has grown 109%, and this success has lifted its valuation to more than 25 times earnings, which is somewhat heady.

Its recent full-year results appear to justify that kind of valuation, with continued growth across its portfolio, rents, profits and dividend. Assura posted a 21.2% increase in investment property to £1.3bn, 16.6% increase in rent roll to £74.4m and a 20% rise in EPS. Investors were duly rewarded with a 9.8% increase in its fully covered dividend, from 2.05p to 2.25p.

Primary investment

Assura also has a strong pipeline with £153m of acquisition and development opportunities, and management stating that the “overwhelming need” for improved primary care premises underpins the company’s future. Both the Conservatives and Labour have made commitments to improve NHS buildings in the next parliament.

The company’s EPS are forecast to grow steadily, by 7% in the year to 31 March 2018, and another 7% in the year afterwards. With a forecast yield of 4%, Assura offers an attractive income stream as well as positive growth prospects. There are good reasons why it isn’t dirt cheap.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Affectionate Asian senior mother and daughter using smartphone together at home, smiling joyfully
Investing Articles

How I’d invest my first £20k ISA to target £4,900 a year from dividend shares

Looking for dividend shares in a new Stocks and Shares ISA, and want diversification too? Here's how I'd go about…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

Yields of up to 7%! I’d consider boosting my income with these FTSE dividend stocks

The London market has some decent-looking dividend stocks right now, and I’m tempted by these two for growing income streams.

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »